Gagnon Advisors »

Maxcyte shares owned by Gagnon Advisors

Quarter-by-quarter ownership of Maxcyte (MXCT) shares owned by Gagnon Advisors from 13F filings

Historical chart of Gagnon Advisors investment in Maxcyte

Tip: Access up to 7 years of quarterly data

All positions including Maxcyte held by Gagnon Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maxcyte by Gagnon Advisors

Quarter filed Position value Share count Share price at filing
2025-03-31 $2.6M 934k 2.73

More positions owned by Gagnon Advisors

Ameresco Cla (AMRC)
Genedx Holdings Corp Com Cl A (WGS)
Freshworks Class A Com (FRSH)
Air Lease Corp Cl A (AL)
Enterprise Products Partners (EPD)
Equinix (EQIX)
Navigator Hldgs SHS (NVGS)
Caredx (CDNA)
DV (DV)
Biolife Solutions Com New (BLFS)
Blackline (BL)
Treace Med Concepts (TMCI)
Vertex Cl A (VERX)
Pacira Pharmaceuticals (PCRX)
Profound Med Corp Com New (PROF)

View all positions for Gagnon Advisors

Top funds holding Maxcyte

BlackRock
Cadian Capital Management
Mirabella Financial Services
Vanguard Group
Vitruvian Partners
Mudita Advisors
AXA Investment Managers
Geode Capital Management
State Street Corporation
Kennedy Capital Management
Dimensional Fund Advisors
Willis Investment Counsel
Citadel Advisors
Northern Trust
Renaissance Technologies

View all funds holding Maxcyte